- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04037969
Comparison of Tear Evaporation Rate With DAILIES TOTAL1 and Biotrue ONEday (MALTESE)
March 25, 2021 updated by: University of Waterloo
The purpose of this pilot study is to compare the effect of DAILIES TOTAL1, a low water content silicone hydrogel lens, and Biotrue ONEday, a high water content hydrogel lens, on the rate of tear evaporation.
The study will also serve to validate the novel, in-house developed evaporimeter.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Centre for Ocular Research & Education
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is at least 17 years of age and has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Has worn soft contact lenses for a minimum of 6 months;
- Currently wears soft contact lenses for at least 4 days per week and 8 hours per day;
- Has an acceptable fit and comfort with both study contact lenses in the powers available;
- Has less than or equal to 1.00DS difference between eyes in their habitual contact lenses;
- Is willing to be awake for at least 2 hours before visit 2;
- Is willing to not wear eye makeup on the day of visit 2 and 3;
- Is willing to not use eye drops or artificial tears on the day of visits 1, 2, and 3;
- Has a wearable pair of spectacles.
Exclusion Criteria:
- Is participating in any concurrent clinical or research study;
- Has any known active* ocular disease and/or infection;
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
- Has known sensitivity to sodium fluorescein dye;
- Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
- Is aphakic;
- Has undergone refractive error surgery;
- Has a known sensitivity to petroleum jelly (Vaseline);
- Has epilepsy and/or a sensitivity to flashing lights;
- Wears toric contact lenses;
- Has any physical impairment that would interfere with holding the evaporimeter;
- Has taken part in another research study within the last 14 days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nesofilcon A/Delefilcon A
Nesofilcon A was worn in right eye and delefilcon A worn in the left eye.
|
Hydrogel contact lens for daily wear
Silicone hydrogel contact lens for daily wear
|
|
Experimental: Delefilcon A/Nesofilcon A
Delefilcon A was worn in right eye and Nesofilcon A worn in the left eye.
|
Hydrogel contact lens for daily wear
Silicone hydrogel contact lens for daily wear
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tear Evaporation Rate With Nesofilcon A
Time Frame: Baseline, 15 minutes post-contact lens, 6 hours post-contact lens
|
Tear film evaporation rate (% relative humidity per second) was performed using a novel evaporimeter as a non-invasive measurement of tear film evaporation.
The slope was calculated from the change in humidity between 7 to 17.5 seconds while the eye was open and between 10 to 17.5 seconds when the eye was closed.
Data from the both eyes were analyzed.
|
Baseline, 15 minutes post-contact lens, 6 hours post-contact lens
|
|
Tear Evaporation Rate With Delefilcon A
Time Frame: Baseline, 15 minutes post-contact lens, 6 hours post-contact lens
|
Tear film evaporation rate (% relative humidity per second) was performed using a novel evaporimeter as a non-invasive measurement of tear film evaporation.
The slope was calculated from the change in humidity between 7 to 17.5 seconds while the eye was open and between 10 to 17.5 seconds when the eye was closed.
Data from the both eyes were analyzed.
|
Baseline, 15 minutes post-contact lens, 6 hours post-contact lens
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 7, 2019
Primary Completion (Actual)
November 26, 2019
Study Completion (Actual)
November 26, 2019
Study Registration Dates
First Submitted
July 26, 2019
First Submitted That Met QC Criteria
July 26, 2019
First Posted (Actual)
July 30, 2019
Study Record Updates
Last Update Posted (Actual)
April 23, 2021
Last Update Submitted That Met QC Criteria
March 25, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 41195
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Evaporative Dry Eye
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
-
I-MED PharmaNot yet recruiting
-
University of California, San FranciscoThat Man May See, Inc.RecruitingEvaporative Loss Dry Eye DiseaseUnited States
-
Superior UniversityActive, not recruitingEvaporative Dry EyePakistan
-
Varol TUNALIProf. Dr. Cemil Tascıoglu Education and Research Hospital Organization; Istanbul... and other collaboratorsEnrolling by invitationDry Eye | Evaporative Dry Eye Disease | Meibomian Gland Dysfunction (Disorder)Turkey (Türkiye)
-
Tear Film Innovations, Inc.Completed
-
University Hospital Sestre MilosrdniceNot yet recruitingDry Eye | Dry Eye Disease | Dry Eye, EvaporativeCroatia
-
He Eye HospitalNot yet recruitingEvaporative Dry EyeChina
-
Laboratorios Thea, SpainCrossdataCompleted
-
Novaliq GmbHCompletedEvaporative Dry Eye DiseaseGermany
Clinical Trials on Nesofilcon A
-
Alcon ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchCompletedRefractive Errors | MyopiaUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Brien Holden VisionCompletedRefractive Error | PresbyopiaAustralia
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedCorneal Infiltrative Events | Corneal InflammationUnited States
-
CooperVision International Limited (CVIL)Completed
-
Johnson & Johnson Vision Care, Inc.Completed